Stifel has revised its price target for Docebo (DOCE) down to $28 from $34, reflecting a more cautious stance on the company's near-term revenue growth and margin trajectory despite its continued leadership in the learning experience platform sector.
- Stifel lowered its price target for Docebo (DOCE) to $28 from $34.
- Recent quarterly revenue growth was 15%, below the 18% consensus estimate.
- Adjusted EBITDA margins declined to 12% from 17% year-over-year.
- Net dollar retention remains strong at over 115%.
- DOCE trades at a forward P/E of approximately 45, viewed as high relative to peers.
- Analysts cite increased competition and macroeconomic pressures as key downside risks.
Stifel has adjusted its investment recommendation for Docebo Inc. (DOCE), reducing the price target from $34 to $28. The change reflects a reassessment of the company’s growth trajectory, particularly around customer acquisition costs and expansion in international markets. Analysts noted that while Docebo maintains a strong product offering and a growing client base, macroeconomic pressures and increased competition in the enterprise learning software space have tempered expectations for margin improvement in the next fiscal year. The downgrade follows Docebo’s most recent quarterly earnings report, which showed revenue growth of 15% year-over-year, slightly below the 18% consensus estimate. The company reported adjusted EBITDA margins of 12%, down from 17% in the same period last year, attributed to higher sales and marketing expenses aimed at scaling its global footprint. Despite these challenges, Docebo continues to report positive net dollar retention exceeding 115%, indicating strong customer stickiness. The stock currently trades at a forward P/E ratio of approximately 45, which Stifel views as elevated relative to peers in the SaaS software sector. While Docebo remains a key player in digital learning infrastructure, the revised target suggests growing skepticism about its ability to sustain high growth rates without significant operational leverage. Market reaction has been muted, with DOCE showing a 1.2% decline in after-hours trading. Investors are focusing on upcoming guidance and the pace of enterprise adoption across verticals such as healthcare and financial services, where Docebo has been expanding its footprint.